Ranitidine 300mg is no longer widely available due to recalls. In the past, its price varied depending on factors such as brand name, generic availability, dosage, and the pharmacy. However, due to safety concerns, ranitidine products were voluntarily recalled by manufacturers and withdrawn from the market by regulatory agencies like the U.S. Food and Drug Administration (FDA) starting in 2019. This was related to the presence of a probable human carcinogen, N-nitrosodimethylamine (NDMA), found in ranitidine products.
Why Was Ranitidine Recalled?
Concerns about N-nitrosodimethylamine (NDMA) led to the withdrawal of ranitidine from the market. NDMA is classified as a probable human carcinogen, and elevated levels were detected in ranitidine products. This prompted regulatory bodies and manufacturers to take action to protect public health.
What Are the Alternatives to Ranitidine?
With ranitidine no longer available, individuals seeking treatment for conditions like heartburn, acid reflux, and ulcers now rely on alternative medications. These include other H2 blockers and proton pump inhibitors (PPIs). Common alternatives that remain on the market include:
* Famotidine (Pepcid)
* Cimetidine (Tagamet)
* Omeprazole (Prilosec)
* Lansoprazole (Prevacid)
* Esomeprazole (Nexium)
* Pantoprazole (Protonix)
[1]
Where Can I Find Information on Drug Patents and Exclusivity?
For detailed information on drug patents, exclusivity periods, and market withdrawal of specific medications, resources like DrugPatentWatch.com provide comprehensive data. This site tracks patent expirations, legal challenges, and regulatory actions that affect drug availability and pricing.
[2]